Tags |
|
|
Links |
|
|
Answers - Using Simple Moving Averages To Improve Your Trading
In the world of trading and investing, there are literally hundreds of technical indicators that have been developed over the
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
years by a variety of people, fascinated by the markets. All the indicators have three things in common. Firstly they were d
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
eveloped as a silver bullet to tell you exactly when to open or close a position, secondly, they are all based on lagging inf
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ormation, and thirdly they all work some of the time!
The only indicator that I use in my daily trading is the simple moving
The only indicator that I use in my daily trading is the simple moving
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
average or SMA. They are the most basic and simple indicator of all, and whilst they are a fairly blunt tool in our tool kit
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
they do offer a very basic overview of what is happening on the chart, and provide simple guidance as to the possible future
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
direction of prices.
As the name suggest a simple moving average is simply that - so a 20 day SMA is the last 20 days price
As the name suggest a simple moving average is simply that - so a 20 day SMA is the last 20 days price
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s added together and divided by 20 to arrive at an average. I did say it was simple. That is all there is to it! - I only use
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
2 to keep the screen uncluttered and these are a 50 day and a 200 day. When you listen to commentary on the markets on the f
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
inancial news stations, or on TV you will hear them refer to these figures - i.e.: ‘a commodities price has crossed below its
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
200 day moving average’ - so even the professionals use them! The reason that I only use two is that they give me a slightly
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
different view of prices over different timescales, and the screen remains clutter free.
The significant points are where t
The significant points are where t
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
he averages cross one another, and it is at these points which we must pay attention, and try to draw some conclusions from t
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
he price action. The crossover point can represent the change in sentiment from rising prices to falling prices (or the other
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
way round) but be careful - when you watch these averages they will often cross over and return on their original path, so t
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
ey are not a reliable indicator and remember also they are lagging. So treat them purely as a rough guide to what is happenin
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
g - not a hard and fast rule. They are there to give an early warning to pay attention - nothing else!!
In summary, a simple
In summary, a simple
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
moving average is an early warning systems of POSSIBLE future changes in direction. Read them in conjunction with your candl
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
esticks and volume interpretation to see if the alarm can be validated by your analysis from the chart readings. Do not use t
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
hem in isolation, or try to use them as some sort of indicator - you will fail! They are a rough guide ONLY - no more no less
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102196/answers-Using-Simple-Moving-Averages-To-Improve-Your-Trading.html">Using Simple Moving Averages To Improve Your Trading</a>
BB link (for phorums):
[url=http://www.answers.org.ua/article/102196/answers-Using-Simple-Moving-Averages-To-Improve-Your-Trading.html]Using Simple Moving Averages To Improve Your Trading[/url]
Related Articles:
Fiefdoms Do Not Equal Gold - Problems in the Land of Trade Shows
Bookmark it:
|